Skip to main content

Coronavirus (COVID-19) Update: FDA Authorizes First Machine Learning-Based Screening Device to Identify Certain Biomarkers That May Indicate COVID-19 Infection

Submitted by tsavage on March 26, 2021 - 10:38 AM

The US Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the first machine learning-based Coronavirus Disease 2019 (COVID-19) non-diagnostic screening device that identifies certain biomarkers that are indicative of some types of conditions, such as hypercoagulation (a condition causing blood to clot more easily than normal).

Content Source:

US Food and Drug Administration (FDA)

Content Author: